    <SEC-DOCUMENT>0001104659-22-046860-index.html : 20220418
    <SEC-HEADER>0001104659-22-046860.hdr.sgml : 20220418
    <ACCEPTANCE-DATETIME>20220418161107
    ACCESSION NUMBER:		0001104659-22-046860
    CONFORMED SUBMISSION TYPE:	DEF 14A
    PUBLIC DOCUMENT COUNT:		4
    CONFORMED PERIOD OF REPORT:	20220602
    FILED AS OF DATE:		20220418
    DATE AS OF CHANGE:		20220418

    FILER:

    	COMPANY DATA:
    		COMPANY CONFORMED NAME:			Annovis Bio, Inc.
    		CENTRAL INDEX KEY:			0001477845
    		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
    		IRS NUMBER:				262540421
    		STATE OF INCORPORATION:			DE
    		FISCAL YEAR END:			1231

    	FILING VALUES:
    		FORM TYPE:		DEF 14A
    		SEC ACT:		1934 Act
    		SEC FILE NUMBER:	001-39202
    		FILM NUMBER:		22832265

    	BUSINESS ADDRESS:
    		STREET 1:		1055 WESTLAKES DRIVE, SUITE 300
    		CITY:			BERWYN
    		STATE:			PA
    		ZIP:			19312
    		BUSINESS PHONE:		610-727-3913

    	MAIL ADDRESS:
    		STREET 1:		1055 WESTLAKES DRIVE, SUITE 300
    		CITY:			BERWYN
    		STATE:			PA
    		ZIP:			19312

    	FORMER COMPANY:
    		FORMER CONFORMED NAME:	QR Pharma, Inc.
    		DATE OF NAME CHANGE:	20091202
    </SEC-HEADER>
    <DOCUMENT>
    <TYPE>DEF 14A
    <SEQUENCE>1
    <FILENAME>tm223565d1_def14a.htm
    <DESCRIPTION>DEF 14A
    <TEXT>
    Document 1 - file: tm223565d1_def14a.htm

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>2
    <FILENAME>tm223565d1_def14asp1img001.jpg
    <DESCRIPTION>GRAPHIC
    <TEXT>
    Document 2 - file: tm223565d1_def14asp1img001.jpg

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>3
    <FILENAME>tm223565d1_def14aimg002.jpg
    <DESCRIPTION>GRAPHIC
    <TEXT>
    Document 3 - file: tm223565d1_def14aimg002.jpg

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>4
    <FILENAME>tm223565d1_def14aimg003.jpg
    <DESCRIPTION>GRAPHIC
    <TEXT>
    Document 4 - file: tm223565d1_def14aimg003.jpg

    </DOCUMENT>
    </SEC-DOCUMENT>